Sana Biotechnology to present SG293 CAR T data at ASGCT meeting
Sana Biotechnology Inc. (NASDAQ: SANA) announced that preclinical data from its SG293 product candidate will be presented at the American ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
